Moderna was last year's third best-performing stock in the S&P--it's now this year's worst.
Moderna Stock Crash Intensifies: Losses Top $130 Billion After Scientists Find Covid Boosters Aren't Halting Omicron Infections
Forbes - 21 Jan 2022 17:32
Moderna was last year's third best-performing stock in the S&P--it's now this year's worst.
Share this Article
Recommended